PT70401A - Pyrimido-(6,1-a)-isochinolin-4-one neue bei ihrer herstellung verwendete zwischenprodukte und verfahren zu ihrer herstellung - Google Patents

Pyrimido-(6,1-a)-isochinolin-4-one neue bei ihrer herstellung verwendete zwischenprodukte und verfahren zu ihrer herstellung

Info

Publication number
PT70401A
PT70401A PT70401A PT7040179A PT70401A PT 70401 A PT70401 A PT 70401A PT 70401 A PT70401 A PT 70401A PT 7040179 A PT7040179 A PT 7040179A PT 70401 A PT70401 A PT 70401A
Authority
PT
Portugal
Prior art keywords
pyrimido
isochinolin
manufacture
production
intermediates used
Prior art date
Application number
PT70401A
Other languages
German (de)
English (en)
Portuguese (pt)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT70401A publication Critical patent/PT70401A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT70401A 1978-11-03 1979-11-02 Pyrimido-(6,1-a)-isochinolin-4-one neue bei ihrer herstellung verwendete zwischenprodukte und verfahren zu ihrer herstellung PT70401A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782847693 DE2847693A1 (de) 1978-11-03 1978-11-03 Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen

Publications (1)

Publication Number Publication Date
PT70401A true PT70401A (de) 1979-12-01

Family

ID=6053766

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70401A PT70401A (de) 1978-11-03 1979-11-02 Pyrimido-(6,1-a)-isochinolin-4-one neue bei ihrer herstellung verwendete zwischenprodukte und verfahren zu ihrer herstellung

Country Status (18)

Country Link
US (1) US4400506A (enExample)
EP (1) EP0010759B1 (enExample)
JP (1) JPS5564587A (enExample)
AT (1) ATE21104T1 (enExample)
AU (1) AU538039B2 (enExample)
CA (1) CA1123434A (enExample)
DE (2) DE2847693A1 (enExample)
DK (1) DK465879A (enExample)
ES (2) ES8102125A1 (enExample)
FI (1) FI66865C (enExample)
GR (1) GR74082B (enExample)
HU (1) HU181884B (enExample)
IL (1) IL58609A0 (enExample)
NO (1) NO793537L (enExample)
NZ (1) NZ191994A (enExample)
PH (1) PH15281A (enExample)
PT (1) PT70401A (enExample)
ZA (1) ZA795888B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64370C (fi) * 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
FR2470130A2 (fr) * 1979-11-21 1981-05-29 Hoechst Ag Derives de pyrimido (6,1-a) isoquinoleine-4-one, leur procede de preparation et leur application en therapeutique
DE3126837A1 (de) * 1981-07-08 1983-01-27 Hoechst Ag, 6000 Frankfurt Triazino-(2,1-a)isochinolinderivate
DE3135831A1 (de) * 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4612376A (en) * 1983-03-25 1986-09-16 Fujisawa Pharmaceutical Co., Ltd. Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
ZW6284A1 (en) * 1983-05-05 1985-10-30 Hoffmann La Roche Novel pyrimidone derivatives
DK1165558T3 (da) * 1999-03-31 2004-02-09 Vernalis Ltd Pyrimido[6,1-a]isoquinolin-4-on-derivater
PL200923B1 (pl) * 1999-08-21 2009-02-27 Nycomed Gmbh Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu
TWI347845B (en) * 2002-03-06 2011-09-01 Nycomed Gmbh Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
CA2920856C (en) 2013-08-09 2026-03-03 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
GB201613054D0 (en) 2016-07-28 2016-09-14 Verona Pharma Plc New compound and process
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
CN121620356A (zh) 2023-06-26 2026-03-06 维罗纳制药公司 包含恩塞芬汀的颗粒组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL251051A (enExample) * 1959-05-02
US3081306A (en) * 1959-11-04 1963-03-12 Pfizer & Co C 2, 4-dioxo-3-aralkylaza-9, 10-di(lower alkoxy)-1, 2, 3, 4, 6, 7-hexahydro-11b-h-benzopyridocolines
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
US3476755A (en) * 1967-01-17 1969-11-04 Edward C Taylor 8,13-diazasteroids
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
US3876788A (en) * 1970-08-27 1975-04-08 Burroughs Wellcome Co Heterocyclic compounds in the treatment of inflammatory of arthritic conditions
DE2720085A1 (de) * 1977-05-05 1978-11-16 Hoechst Ag Pyrimido(6,1-a)isochinolin-2-on- derivate
IN147624B (enExample) 1976-12-10 1980-05-03 Hoechst Pharma
FI64370C (fi) * 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen

Also Published As

Publication number Publication date
ZA795888B (en) 1980-10-29
DK465879A (da) 1980-05-04
DE2847693A1 (de) 1980-05-22
AU538039B2 (en) 1984-07-26
ES8103083A1 (es) 1981-02-16
US4400506A (en) 1983-08-23
NZ191994A (en) 1982-09-07
EP0010759A2 (de) 1980-05-14
ATE21104T1 (de) 1986-08-15
NO793537L (no) 1980-05-06
GR74082B (enExample) 1984-06-06
HU181884B (en) 1983-11-28
EP0010759A3 (en) 1981-08-19
ES493011A0 (es) 1981-02-16
FI793430A7 (fi) 1980-05-04
JPS5564587A (en) 1980-05-15
IL58609A0 (en) 1980-02-29
CA1123434A (en) 1982-05-11
EP0010759B1 (de) 1986-07-30
FI66865B (fi) 1984-08-31
PH15281A (en) 1982-11-02
DE2967610D1 (en) 1986-09-04
ES485489A0 (es) 1980-12-16
FI66865C (fi) 1984-12-10
ES8102125A1 (es) 1980-12-16
AU5245379A (en) 1980-05-08

Similar Documents

Publication Publication Date Title
AU538039B2 (en) Pyrimido (6,1-a)isoquinolin-4-ones
ATE1238T1 (de) Neue 1,4-dihydropyridinverbindungen, verfahren zu ihrer herstellung, die genannten verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser arzneimittel.
DE19775011I2 (de) Chinolinderivate Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekaempfung unerwuenschten Planzenwuchses
ATE26274T1 (de) Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung.
AT366039B (de) Verfahren zur herstellung von neuen dibenzo(b,d) pyranen und saeureadditionssalzen dieser verbindun-gen
ATE3771T1 (de) Dimethylphosphinyl-alkanphosphonsaeuren, ein verfahren zu ihrer herstellung und ihre verwendung als gipsabbindeverzoegerer.
DE3865230D1 (de) Beta-d-phenyl-thioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
DE3667660D1 (de) Chinolylglycinamidderivate, verfahren zu ihrer herstellung und therapeutische verwendung als psychotrope.
ATE30719T1 (de) Imino-2-pyrrolidine, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE38515T1 (de) Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung.
ATE127512T1 (de) Verfahren zur herstellung hydrophilisierter triglyceride.
AT374200B (de) Verfahren zur herstellung von neuen halogenvincamonderivaten
ATE31928T1 (de) Acylamino-4-aza-1-adamantane, verfahren zu ihrer herstellung und ihre anwendung in der therapeutik.
ATE9330T1 (de) Phenethanolamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE2794T1 (de) 1-n-alkylsisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69032857D1 (de) 2-spirocyclopropylcephalosporinderivate und verfahren zu ihrer herstellung
ATE18404T1 (de) Thiazolo(2,3-b)-chinazolone und verfahren zu ihrer herstellung.
PT68989A (de) Verfahren zur herstellung von neuen arylaminoimidazolinderivaten
AT375939B (de) Verfahren zur herstellung von neuen 15-halogen-e- homoeburnanderivaten, von deren saeureadditions- salzen, epimeren und optischen antipoden
DD134769A1 (de) Verfahren zur herstellung von 3-oxo-oestra-4,9,11-trienen
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE25517T1 (de) Delta-1-pyrrolin-thiolactimaether und verfahren zu ihrer herstellung.
ATE16186T1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung.
ATE23340T1 (de) 3-alkylthio-2-0-carbamoylpropan-1,2-diol-1-0phosphocholine und verfahren zu ihrer herstellung.